SMARCA4 Mutation
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors (NCT07284186) | Plexium, Inc. | 2025-12-01 |
| A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation (NCT06560645) | Prelude Therapeutics | 2024-11-04 |
Track SMARCA4 Mutation automatically
Every clearance here is in the API, with alerts when new ones post.